Nu Skin ENTERPRISES, Inc. (NUS) intrinsic value & 10-year financials

Nu Skin ENTERPRISES, Inc. (NUS) has a Graham intrinsic value of $36.93 per share. At $5.14 on Oct 17, 2026, the stock trades 86% below that value. Over the last 10 fiscal years revenue shrank 4.3% a year to $1.5B, with an average return on invested capital of 12.0%.

Graham intrinsic value
$36.93
Share price (Oct 17, 2026)
$5.14
Price vs Graham value
86% below
Market cap
$258.5M
Revenue (FY2025)
$1.5B
Revenue growth (10-yr CAGR)
-4.3%
ROIC (10-yr avg)
12.0%
Free cash flow (FY2025)
$46.0M

NUS 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $1.5B $160.2M $3.18 $46.0M 4.4% 6.0%
FY2024 $1.7B -$146.6M -$2.95 $70.2M -8.8% -12.2%
FY2023 $2.0B $8.6M $0.17 $60.1M 2.5% 2.1%
FY2022 $2.2B $104.8M $2.07 $49.0M 5.0% 10.2%
FY2021 $2.7B $147.3M $2.86 $73.0M 8.7% 14.9%
FY2020 $2.6B $191.4M $3.63 $315.3M 10.0% 19.7%
FY2019 $2.4B $173.6M $3.10 $111.9M 11.0% 19.8%
FY2018 $2.7B $121.9M $2.16 $132.4M 9.0% 17.9%
FY2017 $2.3B $129.4M $2.36 $242.4M 12.0% 19.7%
FY2016 $2.2B $143.1M $2.55 $225.0M 10.5% 21.5%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

NU SKIN ENTERPRISES, INC. is facing top-line stagnation, with revenue contracting over the decade.

NU SKIN ENTERPRISES, INC. returns on capital have been average, hovering around 12.0% ROIC over the decade.

Over the decade, NU SKIN ENTERPRISES, INC. shows that management has aggressively returned capital to shareholders by retiring 10.3% of outstanding shares.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, NU SKIN ENTERPRISES, INC. is modeled at 2.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $36.93 per share.

NUS stock: frequently asked questions

What is the intrinsic value of Nu Skin ENTERPRISES, Inc. (NUS) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 2.5% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, NUS's intrinsic value is about $36.93 per share.

Is NUS stock undervalued?

At $5.14 (close on Oct 17, 2026), NUS trades 86% below its Graham value of $36.93. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Nu Skin ENTERPRISES, Inc. grown?

Revenue went from $2.2B in fiscal 2016 to $1.5B in fiscal 2025, a compound annual growth rate of -4.3%. Net income was $160.2M in fiscal 2025.

Does Nu Skin ENTERPRISES, Inc. generate free cash flow?

Nu Skin ENTERPRISES, Inc. generated $46.0M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 10 of the last 10 reported years.

What is NUS's return on invested capital?

Average ROIC over the last 10 fiscal years was 12.0%, and average return on equity was 13.0%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this NUS data come from?

From Nu Skin ENTERPRISES, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 8, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar wholesale-drugs, proprietaries & druggists' sundries stocks